glp-1 colorectal cancer risk study november 2025 Long-term in users of agonists in Denmark: a nationwide emulated trial Mapping the effectiveness and risks

HRT is widely prescribed in primary care women with obesity are most likely to be using a transdermal (TD) form of oestrogen, which will not be affected by a GLP-1 agonist

Door Step Delivery Quick and Secure No Hidden Charges Pay only what's shown 18K Pincodes Served With Trust & Reliability Related Products

Preserving muscle mass is crucial for strength and mobility

Any returned items will be refunded to the original method of payment used at checkout, at the price paid and subject to our Return Policy found at The Consultation 10% off your Purchase (the Consultation Promotion ) is only available at select standalone DECIEM/The Ordinary stores in select countries ( Eligible Locations - see full list below) during store hours from February 26th, 2026, to February 26th, 2027 (the Consultation Promotion Period )

Thereafter, dose can be scheduled from the date of the last dose

Trial status: Recruitment started in June 2025 and is ongoing